Dopamine receptor agonist

This page covers all Dopamine receptor agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Dopamine receptors (D1-D5), Dopamine receptor.

Targets

Dopamine receptors (D1-D5) · Dopamine receptor

Marketed (1)

• Dopaminergic Agonists · Sandoz · Neurology
  Dopaminergic agonists activate dopamine receptors in the brain to increase dopamine signaling.

Phase 3 pipeline (2)

• DEP-Ru · Beijing Friendship Hospital · Neurology
  DEP-Ru is a small molecule that targets the dopamine receptor.
• SPD503 (2 mg) · Shire · Neurology
  SPD503 is a dopamine receptor agonist.